Holen Sie sich die Stockscreener-App
0.60
2.04%
0.012
Schlusskurs vom Vortag:
$0.588
Offen:
$0.597
24-Stunden-Volumen:
28,262
Relative Volume:
0.46
Marktkapitalisierung:
$3.95M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-8.70M
KGV:
-0.1702
EPS:
-3.5262
Netto-Cashflow:
$-6.34M
1W Leistung:
-1.91%
1M Leistung:
-9.31%
6M Leistung:
-56.52%
1J Leistung:
-65.91%
1-Tages-Spanne:
$0.597
$0.615
1-Wochen-Bereich:
$0.5706
$0.6343
52-Wochen-Spanne:
$0.5025
$2.68
Galmed Pharmaceuticals Ltd Stock (GLMD) Company Profile
Firmenname
Galmed Pharmaceuticals Ltd
Sektor
Branche
Telefon
-
Adresse
-
Compare GLMD vs VRTX, REGN, ALNY, ARGX, INSM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
GLMD
Galmed Pharmaceuticals Ltd
|
0.60 | 3.95M | 0 | -8.70M | -6.34M | -3.5262 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 115.58B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 79.23B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 43.59B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 43.26B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 31.97B | 606.42M | -1.28B | -997.58M | -6.403 |
Galmed Pharmaceuticals Ltd Stock (GLMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2020-05-22 | Herabstufung | B. Riley FBR | Buy → Neutral |
| 2020-02-04 | Eingeleitet | Craig Hallum | Buy |
| 2020-01-30 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2019-12-02 | Eingeleitet | Canaccord Genuity | Buy |
| 2018-12-12 | Eingeleitet | B. Riley FBR | Buy |
| 2018-08-02 | Bestätigt | Maxim Group | Buy |
| 2018-07-13 | Eingeleitet | Stifel | Buy |
| 2018-07-12 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2018-06-12 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-15 | Hochstufung | Maxim Group | Hold → Buy |
| 2018-02-14 | Herabstufung | Maxim Group | Buy → Hold |
| 2018-02-12 | Bestätigt | H.C. Wainwright | Buy |
| 2017-11-15 | Eingeleitet | ROTH Capital | Buy |
| 2017-08-08 | Bestätigt | H.C. Wainwright | Buy |
| 2017-07-31 | Bestätigt | Maxim Group | Buy |
| 2016-08-01 | Bestätigt | Maxim Group | Buy |
| 2016-07-06 | Fortgesetzt | ROTH Capital | Buy |
| 2016-03-28 | Fortgesetzt | H.C. Wainwright | Buy |
| 2015-06-23 | Eingeleitet | H.C. Wainwright | Buy |
| 2015-05-06 | Eingeleitet | Sun Trust Rbsn Humphrey | Buy |
Alle ansehen
Galmed Pharmaceuticals Ltd Aktie (GLMD) Neueste Nachrichten
Sectors Review: Can Galmed Pharmaceuticals Ltd deliver consistent dividendsMarket Rally & Low Risk Growth Stock Ideas - baoquankhu1.vn
Galmed (GLMD) director David Sidransky reports initial share and option holdings - Stock Titan
Galmed (GLMD) CFO details Ordinary Share, option and RSU holdings - Stock Titan
[Form 3] Galmed Pharmaceuticals Ltd. In... - Stock Titan
Galmed Pharmaceuticals (NASDAQ: GLMD) CAO reports shares, options and RSUs - Stock Titan
Galmed Pharmaceuticals Ltd. (GLMD) CSO details option holdings - Stock Titan
Galmed (GLMD) director Amir Poshinski details shares, RSUs and options - Stock Titan
Galmed (GLMD) director discloses multiple stock option grants - Stock Titan
Aug Chart Watch: Will Galmed Pharmaceuticals Ltd. stock maintain dividend yieldShort Setup & Advanced Swing Trade Entry Plans - Naître et grandir
Smart Money: Is Galmed Pharmaceuticals Ltd stock a good dividend stockMarket Growth Review & Reliable Price Breakout Signals - baoquankhu1.vn
Galmed Pharmaceuticals Shares Edge Higher Following CEO’s Positive Update - MSN
Galmed Pharmaceuticals Shareholders Approve Proposal at Special Meeting - TipRanks
Galmed Pharmaceuticals (NASDAQ: GLMD) shareholders back proposal at March 5 special meeting - Stock Titan
Galmed Pharmaceuticals Adjourns Special Shareholder Meeting for Lack of Quorum - TipRanks
Galmed Pharmaceuticals (GLMD) adjourns shareholder meeting and resets date - Stock Titan
Form 6K Galmed Pharmaceuticals Ltd. For: 4 March By Investing.com - Investing.com Canada
GLMD.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
GLMD Should I Buy - Intellectia AI
Buyout Rumor: Will Galmed Pharmaceuticals Ltd benefit from government policyWeekly Trend Report & Fast Momentum Entry Tips - baoquankhu1.vn
GLMD PE Ratio & Valuation, Is GLMD Overvalued - Intellectia AI
Can Galmed Pharmaceuticals Ltd. ride the EV waveWeekly Trend Recap & Daily Profit Focused Screening - mfd.ru
Why Galmed Pharmaceuticals Ltd. (GPH) stock is a must watch tickerTrade Ideas & Comprehensive Market Scan Reports - mfd.ru
Dip Buying: Why Galmed Pharmaceuticals Ltd. (GPH) stock is a must watch tickerTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Can Galmed Pharmaceuticals Ltd. deliver consistent dividends2025 Price Targets & Long-Term Growth Portfolio Plans - mfd.ru
What’s the RSI of Galmed Pharmaceuticals Ltd. stockTreasury Yields & Community Consensus Picks - mfd.ru
Galmed Pharmaceuticals schedules special shareholder meeting for March 4 - Investing.com Nigeria
Galmed Pharmaceuticals Sets March 4 Vote on Reverse Stock Split to Address Nasdaq Listing Deficiency - TipRanks
12 Health Care Stocks Moving In Thursday's After-Market Session - Benzinga
Aug Summary: Will Galmed Pharmaceuticals Ltd benefit from government policyJuly 2025 Weekly Recap & Daily Chart Pattern Signal Reports - baoquankhu1.vn
Galmed Pharmaceuticals Receives Nasdaq Minimum Bid Price Deficiency Notice - TipRanks
Galmed Pharmaceuticals receives Nasdaq minimum bid price notice - Investing.com
Galmed Pharmaceuticals Announces Receipt of Nasdaq Minimum Bid Price Notification - PR Newswire
Published on: 2026-01-20 07:51:30 - bollywoodhelpline.com
Market Review: Can Home Bancorp Inc maintain its current growth rateQuarterly Portfolio Summary & Consistent Profit Alerts - baoquankhu1.vn
How volatile is Galmed Pharmaceuticals Ltd stockTrade Analysis Summary & Scalable Portfolio Growth Methods - baoquankhu1.vn
Price Action: What are IBKRs technical support levelsQuarterly Trade Report & Short-Term High Return Strategies - baoquankhu1.vn
Galmed Pharmaceuticals (NASDAQ:GLMD) Share Price Crosses Below 50-Day Moving Average – Should You Sell? - Defense World
Trade Recap: Is Galmed Pharmaceuticals Ltd stock a good dividend stock2025 Analyst Calls & Long-Term Growth Stock Strategies - baoquankhu1.vn
Chart Watch: Will Galmed Pharmaceuticals Ltd benefit from government policyWeekly Investment Report & Smart Investment Allocation Insights - baoquankhu1.vn
Stock Report: Is Galmed Pharmaceuticals Ltd in a long term uptrendJuly 2025 Market Mood & Daily Growth Stock Tips - baoquankhu1.vn
Galmed Pharmaceuticals Secures Shareholder Approval at Annual Meeting - MSN
Volume Report: How Galmed Pharmaceuticals Ltd GPH stock expands through international marketsPortfolio Value Report & Free Verified High Yield Trade Plans - Bộ Nội Vụ
Will Galmed Pharmaceuticals Ltd. stock outperform Dow Jones indexPortfolio Value Report & Verified Short-Term Plans - ulpravda.ru
What makes Galmed Pharmaceuticals Ltd. (GPH) stock appealing to growth investorsMarket Risk Analysis & Fast Exit and Entry Trade Guides - Улправда
What technical charts say about Galmed Pharmaceuticals Ltd. stockMarket Performance Summary & Stepwise Entry and Exit Trade Signals - ulpravda.ru
How Galmed Pharmaceuticals Ltd. stock reacts to job market data2025 Performance Recap & Low Drawdown Momentum Ideas - Улправда
Can Galmed Pharmaceuticals Ltd. stock surprise with earnings upsideJuly 2025 Big Picture & Advanced Swing Trade Entry Alerts - Улправда
How Galmed Pharmaceuticals Ltd. (GPH) stock expands through international marketsJuly 2025 Review & Free Technical Confirmation Trade Alerts - Улправда
Is Galmed Pharmaceuticals Ltd. (GPH) stock worth buying before Fed actionJuly 2025 Drop Watch & Smart Investment Allocation Insights - Улправда
Published on: 2026-01-09 00:35:39 - ulpravda.ru
Galmed Pharmaceuticals Ltd.Ordinary Shares (NQ: GLMD - FinancialContent
Finanzdaten der Galmed Pharmaceuticals Ltd-Aktie (GLMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):